Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Adam P Mecca^{1

2}, Christopher H van Dyck^{1

2

3

4}

Affiliations

¹ Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
² Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
³ Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.
⁴ Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.

Comment

Adam P Mecca et al. Alzheimers Dement. 2021 Feb.

. 2021 Feb;17(2):316-317.

doi: 10.1002/alz.12190. Epub 2020 Oct 12.

Adam P Mecca^{1

2}, Christopher H van Dyck^{1

2

3

4}

¹ Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
² Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
³ Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.
⁴ Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.

No abstract available

Comment on

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
Mecca AP, Chen MK, O'Dell RS, Naganawa M, Toyonaga T, Godek TA, Harris JE, Bartlett HH, Zhao W, Nabulsi NB, Wyk BCV, Varma P, Arnsten AFT, Huang Y, Carson RE, van Dyck CH. Mecca AP, et al. Alzheimers Dement. 2020 Jul;16(7):974-982. doi: 10.1002/alz.12097. Epub 2020 May 13. Alzheimers Dement. 2020. PMID: 32400950 Free PMC article.
Synaptic impairment: The new battlefield of Alzheimer's disease.
Francesco DL, Koch G. Francesco DL, et al. Alzheimers Dement. 2021 Feb;17(2):314-315. doi: 10.1002/alz.12189. Epub 2020 Sep 18. Alzheimers Dement. 2021. PMID: 32946657 No abstract available.

1. Mecca AP, Chen MK, O’Dell RS, et al. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET. Alzheimer’s Dement. 2020;16(7):974–982. - PMC - PubMed
1. Bastin C, Bahri MA, Meyer F, et al. In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography. Eur J Nucl Med Mol Imaging. 2019;47(2):390–402. - PubMed
1. Chen MK, Mecca AP, Naganawa M, et al. Assessing synaptic density in alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA neurology. 2018;75(10): 1215–1224. - PMC - PubMed
1. Koch G, Di Lorenzo F, Bonni S, Ponzo V, Caltagirone C, Martorana A. Impaired LTP- but not LTD-like cortical plasticity in Alzheimer’s disease patients. J Alzheimers Dis. 2012;31(3):593–599. - PubMed